Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Cardiology Journal
MENU
Shortcuts Submit an article CJ Guide for Authors (new) Recent articles Special collections Ahead Of Print APIS-S Online Calculator OCT Contrast Calculator Reviewers 2022

open access

Vol 27, No 4 (2020)
Editorial
Submitted: 2020-05-29
Accepted: 2020-07-12
Published online: 2020-09-10
View PDF Download PDF file
Get Citation

The legacy of ISCHEMIA

Umberto Ianni1, Francesco Radico1, Fabrizio Ricci2, Matteo Perfetti3, Federico Archilletti1, Giulia Renda1, Nicola Maddestra3, Sabina Gallina2, Marco Zimarino1
DOI: 10.5603/CJ.2020.0108
·
Pubmed: 32929700
·
Cardiol J 2020;27(4):329-335.
Affiliations
  1. Institute of Cardiology, “G. d’Annunzio University”, Chieti, Italy
  2. Department of Neuroscience, Imaging and Clinical Sciences,, via dei Vestini, 66013 Chieti, Italy
  3. Cath Lab - SS. Annunziata Hospital, Chieti, Italy

open access

Vol 27, No 4 (2020)
Editorial
Submitted: 2020-05-29
Accepted: 2020-07-12
Published online: 2020-09-10

Abstract

Not available

Abstract

Not available

Full Text:

View PDF Download PDF file
Get Citation
About this article
Title

The legacy of ISCHEMIA

Journal

Cardiology Journal

Issue

Vol 27, No 4 (2020)

Article type

Editorial

Pages

329-335

Published online

2020-09-10

Page views

740

Article views/downloads

788

DOI

10.5603/CJ.2020.0108

Pubmed

32929700

Bibliographic record

Cardiol J 2020;27(4):329-335.

Authors

Umberto Ianni
Francesco Radico
Fabrizio Ricci
Matteo Perfetti
Federico Archilletti
Giulia Renda
Nicola Maddestra
Sabina Gallina
Marco Zimarino

References (35)
  1. Maron D, Hochman J, Reynolds H, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020; 382(15): 1395–1407.
    CrossRef
  2. Spertus J, Jones P, Maron D, et al. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. N Engl J Med. 2020; 382(15): 1408–1419.
    CrossRef
  3. Boden WE, O'Rourke RA, Teo KK, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356(15): 1503–1516.
    CrossRefPubMed
  4. Al-Lamee R, Thompson D, Dehbi HM, et al. ORBITA investigators. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018; 391(10115): 31–40.
    CrossRefPubMed
  5. Maron DJ, Hochman JS, O'Brien SM, et al. ISCHEMIA Trial Research Group. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. Am Heart J. 2018; 201: 124–135.
    CrossRefPubMed
  6. Shaw LJ, Berman DS, Maron DJ, et al. COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008; 117(10): 1283–1291.
    CrossRefPubMed
  7. Shaw LJ, Berman DS, Picard MH, et al. Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC Cardiovasc Imaging. 2014; 7(6): 593–604.
    CrossRefPubMed
  8. Maron D, Harrington R, Hochman J. Planning and Conducting the ISCHEMIA Trial. Circulation. 2018; 138(14): 1384–1386.
    CrossRef
  9. Shaw L, Nagel E, Salerno M, et al. Cardiac Imaging in the Post ISCHEMIA Trial Era - A Multi Society Viewpoint. JACC: Cardiovasc Imaging. 2020.
  10. Jang JJ, Bhapkar M, Coles A, et al. PROMISE Investigators. Predictive model for high-risk coronary artery disease. Circ Cardiovasc Imaging. 2019; 12(2): e007940.
    CrossRefPubMed
  11. Ge Y, Pandya A, Steel K, et al. Cost-Effectiveness analysis of stress cardiovascular magnetic resonance imaging for stable chest pain syndromes. JACC Cardiovasc Imaging. 2020; 13(7): 1505–1517.
    CrossRefPubMed
  12. Murthy VL, Eagle KA. ISCHEMIA: A Search for clarity and why we may not find it. Am Heart J. 2018; 203: 82–84.
    CrossRefPubMed
  13. Cortés C, Johnson TW, Silber S, et al. ISCHEMIA trial: the long-awaited evidence to confirm our prejudices. Cardiol J. 2020.
  14. Antman EM, Braunwald E. Managing stable ischemic heart disease. N Engl J Med. 2020; 382(15): 1468–1470.
    CrossRefPubMed
  15. Koskinas KC, Ndrepepa G, Räber L, et al. Prognostic impact of periprocedural myocardial infarction in patients undergoing elective percutaneous coronary interventions. Circ Cardiovasc Interv. 2018; 11(12): e006752.
    CrossRefPubMed
  16. Stone G, Kappetein A, Sabik J, et al. Five-year outcomes after PCI or CABG for left main coronary disease. N Engl J Med. 2019; 381(19): 1820–1830.
    CrossRef
  17. Ben-Yehuda O, Chen S, Redfors B, et al. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial. Eur Heart J. 2019; 40(24): 1930–1941.
    CrossRefPubMed
  18. Zannad F, Rossignol P. Cardiovascular outcome trials in patients with advanced kidney disease: time for action. Circulation. 2017; 135(19): 1769–1771.
    CrossRefPubMed
  19. Bangalore S, Maron DJ, O'Brien SM, et al. ISCHEMIA-CKD Research Group. Management of coronary disease in patients with advanced kidney disease. N Engl J Med. 2020; 382(17): 1608–1618.
    CrossRefPubMed
  20. Bajaj NS, Singh A, Zhou W, et al. Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in patients with chronic kidney impairment. Circulation. 2020; 141(1): 21–33.
    CrossRefPubMed
  21. Reynolds HR. Natural history of symptoms and stress echo findings in patients with moderate or severe ischemia and no obstructive CAD (INOCA): the NHLBI-funded CIAO ancillary study to the ISCHEMIA trial. ACC 2020, March 30, 2020.
  22. Radico F, Zimarino M, Fulgenzi F, et al. Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis. Eur Heart J. 2018; 39(23): 2135–2146.
    CrossRefPubMed
  23. Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol. 2013; 62(16): 1421–1431.
    CrossRefPubMed
  24. Zimarino M, Ricci F, Romanello M, et al. Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies. Catheter Cardiovasc Interv. 2016; 87(1): 3–12.
    CrossRefPubMed
  25. Zimarino M, Curzen N, Cicchitti V, et al. The adequacy of myocardial revascularization in patients with multivessel coronary artery disease. Int J Cardiol. 2013; 168(3): 1748–1757.
    CrossRefPubMed
  26. Lee HS, Lee JM, Nam CW, et al. Consensus document for invasive coronary physiologic assessment in Asia-Pacific countries. Cardiol J. 2019; 26(3): 215–225.
    CrossRefPubMed
  27. Gutiérrez-Chico JL, Chen Y, Yu W, et al. Diagnostic accuracy and reproducibility of optical flow ratio for functional evaluation of coronary stenosis in a prospective series. Cardiol J. 2020 [Epub ahead of print].
    CrossRefPubMed
  28. Gutiérrez-Chico JL, Louvard Y. DECISION-CTO: A "negative" clinical trial? Really? Cardiol J. 2017; 24(3): 231–233.
    CrossRefPubMed
  29. Zimarino M, Briguori C, Amat-Santos IJ, et al. Mid-term outcomes after percutaneous interventions in coronary bifurcations. Int J Cardiol. 2019; 283: 78–83.
    CrossRefPubMed
  30. Werner GS, Martin-Yuste V, Hildick-Smith D, et al. EUROCTO trial investigators. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018; 39(26): 2484–2493.
    CrossRefPubMed
  31. Giustino G, Chieffo A, Palmerini T, et al. Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. J Am Coll Cardiol. 2016; 68(17): 1851–1864.
    CrossRefPubMed
  32. Zimarino M, Renda G, De Caterina R. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents. Drugs. 2005; 65(6): 725–732.
    CrossRefPubMed
  33. Zimarino M, Corcos T, Favereau X, et al. Rotational coronary atherectomy with adjunctive balloon angioplasty for the treatment of ostial lesions. Cathet Cardiovasc Diagn. 1994; 33(1): 22–27.
    CrossRefPubMed
  34. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 87–165.
  35. Al-Lamee R, Jacobs AK. The ISCHEMIA Trial: Was it Worth the Wait? Circulation. 2020 [Epub ahead of print].
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl